# Interface Biologics: Research, Toronto, Canada

> Interface Biologics: Interface Biologics is a Canadian company based in Toronto, specializing in biomedical polymer and surface-modification technologies.

Source: https://millionrounds.com/startup/interface-biologics (Millionrounds; every figure on the page links to its filing or article)

Canada · [Research startup](https://millionrounds.com/companies)

# Interface Biologics

Interface Biologics is a Canadian company based in Toronto, specializing in biomedical polymer and surface-modification technologies.

Funding reported Last round: Series B

Research Toronto, Canada

Company summary

- **Founded:** 2001 25 years old
- **Team:** 7 1 to 10 people
- **Funding reported:** 32M as listed, currency not stated
- **Last round:** Series B Jan 2015

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Interface Biologics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Interface Biologics

Interface Biologics is a Canadian company based in Toronto, specializing in biomedical polymer and surface-modification technologies.

The company focuses on enhancing the safety and effectiveness of medical devices that interact with blood, tissue, or other biological fluids. Their core technologies include surface-modifying macromolecules and polymer-enabled combination drug delivery devices. The Endexo® technology is part of their surface-modification platform, which improves biocompatibility and helps reduce complications such as infections and thrombus formation on medical devices. Additionally, Interface Biologics has developed sustained local drug delivery technology, particularly aimed at ophthalmology applications. The company's innovations have been utilized in FDA-approved medical devices and have undergone clinical validation for their effectiveness in reducing infection and thrombus-related issues. Interface Biologics originated as a spinoff from the University of Toronto and has made significant strides in the biomedical field.

## What company datasets say Interface Biologics raised

Funding, as reported

Reported in all **32M** in the source's currency

Rounds **6**

Last round **Series B**

Last round date **Jan 2015**

Investors listed **6**

## Founders and team

From Interface Biologics's own website: 1 founder.

**Thomas P. Reeves** Co-Founder & President & CEO

## The company, in detail

What they build

Known for

surface area tuning health care drug release kinetics biotechnology research manufacturing sustained drug release regulatory pathway ophthalmic therapeutics sustained release biocompatible materials hospital & health care predictable drug release biodegradable ophthalmic implants medical partnership development health

Built with from their website

Google Tag Manager Amazon CloudFront Viewport Meta Facebook SDK Priority Hints Microsoft Exchange Microsoft 365 Apps & Services Open Graph jQuery Snowplow

+8 more

RSS Apple iOS Facebook Social Plugins Duda Google Analytics GoDaddy Domains Amazon AWS Microsoft Exchange Online

- **Sector:** Research
- **Industry code:** NAICS 33911, SIC 2834, 3841
- **Region:** Ontario
- **Revenue:** 15M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/interface-biologics-inc)

## Research in Canada

Startups like it

- [**Altis Labs** Toronto · founded 2019 *Raised*](https://millionrounds.com/company/altis-labs)
- [**Sitka Biopharma** Vancouver · founded 2013 *Raised*](https://millionrounds.com/company/sitka-biopharma)
- [**ServiceNow AI Research** Montreal · founded 2016](https://millionrounds.com/startup/servicenow-ai-research)
- [**DalCor Pharmaceuticals** Montreal · founded 2015](https://millionrounds.com/startup/dalcor-pharmaceuticals)
- [**Notch Therapeutics** Vancouver · founded 2018](https://millionrounds.com/startup/notch-therapeutics)
- [**chemical.ai** Toronto · founded 2018](https://millionrounds.com/startup/chemical-ai)
- [**Congruence Therapeutics** Montreal · founded 2021](https://millionrounds.com/startup/congruence-therapeutics)
- [**Zucara Therapeutics Inc.** Toronto · founded 2015](https://millionrounds.com/startup/zucara-therapeutics-inc)

## Is this your company?

Add your raise, your deck and your story, and put Interface Biologics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)